ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 to $850 Million
Valneva Provides Updated 2023 Financial Guidance
Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
China Medical University Hospital's Breakthrough Drug of 'Allogenic mRNA CAR-T' & Its GenAI 'gHi' Standing Out in Healthcare+ Expo (Taiwan) 2023
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
Profound Medical Announces Proposed Public Offering of Common Shares
Calliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium Capital
60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024
 3   4   5   6   7     8    9   10   11   12   13 
 <<   <   >   >>